Bio/Pharma’s Roadmap for Success in 2026
February 11, 2026
Qinecsa Chief Operating Officer, John Cogan, has been featured in The Pharma Navigator latest issue, where he discusses trends from 2025 for the bio/pharma industry.
Qinecsa Chief Operating Officer, John Cogan, has been featured in The Pharma Navigator latest issue, where he discusses trends from 2025 for the bio/pharma industry.
Qinecsa VP, Product Management Reportum, Daniel O’Keeffe, has been featured in PharmaTimes Magazine latest issue, where he discusses how AI alone won’t solve pharma’s fragmented
Qinecsa Chief Operating Officer, John Cogan, has been featured in International Pharmaceutical Industry latest issue, where he predicts industry trends for the year ahead and
Applying artificial intelligence (AI) to fragmented and incomplete safety data cannot fill the gap left when the right information has not been captured during initial
Alex will drive global commercial strategy and help scale Qinecsa’s next-generation pharmacovigilance technology across the life sciences ecosystem London, UK – January 12th, 2025 – Qinecsa, the
Qinecsa Chief Operating Officer, John Cogan, has been featured in Bio IT World latest issue, where he predicts trends in artificial intelligence, impact of global
Qinecsa Chief Operating Officer, John Cogan, has been featured in European Pharmaceutical Manufacturer latest issue, where he predicts where is the industry setting its sights for
Ongoing drug safety monitoring is critical to containing risk and keeping patients safe, and with so many channels for reporting adverse events, the workload in
Beena Wood, a drug safety specialist and chief product officer at Qinecsa Solutions, says 2025 has seen a reality check in this regard. In a pharmacovigilance
Beena Wood will build on the pure-bred pharmacovigilance specialist’s deep domain expertise and technology-powered solution portfolio to help reframe the contribution of drug safety London,